Rosana Kapeller has resigned her position as chief scientific officer of Cambridge, MA, biotech company Nimbus Therapeutics. The company said in a news release that she is leaving to “explore an executive leadership role.” Kapeller was one of the founders of Nimbus, which was initially called Nimbus Discovery to reflect its focus on computer-aided drug discovery. The company changed its name to Nimbus Therapeutics in 2015 as it advanced a liver drug toward clinical trials.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
